SCHEMBL900480

SCHEMBL900480

OC(c1cccc(Br)c1)c1nc2ccccc2s1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.70
MAPK1 P28482 2/20 0.56
GAA P10253 1/20 0.56
TSHR P16473 1/20 0.56
HSD17B10 Q99714 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
IDO1 P14902 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.42
APEX1 P27695 1/20 0.41
CASR P41180 1/20 0.40
ALOX5 P09917 1/20 0.40
PDE10A Q9Y233 1/20 0.39
CTSA P10619 1/20 0.39
RAB9A P51151 3/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL900511 0.83 HPGD (1.00) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL900494 0.83 HPGD (0.70) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL10725767 0.83 HPGD (0.50) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL153027 0.77 HPGD (0.54) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL20965302 0.75 HPGD (0.72) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL900715 0.75 GAA (0.73) HPGDMAPK1GAATSHRRAB9A
SCHEMBL900421 0.75 HPGD (0.58) HPGDMAPK1GAATSHRCYP1A2
SCHEMBL900184 0.75 HPGD (0.58) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL27655355 0.74 HPGD (0.50) HPGDMAPK1GAATSHRHSD17B10
SCHEMBL900504 0.74 MAPK1 (0.58) HPGDMAPK1GAATSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 EP disclosed
US-9029357-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2015-05-12 US disclosed
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET SOC CIV (FR) 2015-01-01 US disclosed
US-8802664-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJECT (FR) 2014-08-12 US disclosed
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET (FR) 2013-09-05 US disclosed
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 EP disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 EP disclosed
WO-2012041860-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 HPGD 1014/4885MAPK1 4011/4885GAA 3188/4885
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 HPGD 583/4885MAPK1 3365/4885GAA 2990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.